Annals of the New York Academy of Sciences
June 1, 2002
B. Gough, Syed Z. Imam, Bruce E. Blough et al.
47 citations
Paramethoxyamphetamine (PMA), a drug sold illicitly as 'ecstasy' and linked to fatalities in Australia and the United States, produces neurotoxic effects on dopamine and serotonin systems in rats similar to MDMA and methamphetamine (METH). Extracellular levels of dopamine, its metabolites DOPAC and HVA, serotonin (5-HT), and its metabolite 5-HIAA were measured in the caudate of freely moving rats via microdialysis. METH (2.5 mg/kg) increased dopamine 700% and decreased DOPAC 30% and HVA 50%, with no serotonin changes. MDMA (10 and 20 mg/kg) increased dopamine up to 950% and serotonin up to 575%.
Annals of the New York Academy of Sciences
May 1, 1998
David Frederick, Syed F. Ali, Michael Gillam et al.
32 citations
In rhesus monkeys, the acute behavioral effects of MDMA and dexfenfluramine (d-FEN) were assessed using five food-reinforced tasks measuring learning, memory, attention, time estimation, motivation, and discrimination. After a short-course, high-dose exposure to MDMA (10 mg/kg twice daily for four days), monkeys became less sensitive to the acute behavioral disruption by both drugs, especially d-FEN, and this tolerance was task-specific. In contrast, monkeys similarly exposed to high-dose d-FEN (5 mg/kg) showed no change in sensitivity. Surprisingly, both groups showed similar neurochemical effects—approximately 50% decreases in serotonin in the frontal cortex and hippocampus six months later—yet only MDMA pretreatment induced behavioral tolerance.
Annals of the New York Academy of Sciences
May 1, 1998
Zbigniew Binienda, Michael A Beaudoin, Brett T Thorn et al.
13 citations
Ibogaine, a psychoactive alkaloid with antiaddictive properties, can cause neurotoxicity. In anesthetized rats, a single 50 mg/kg dose of ibogaine produced an immediate decrease in heart rate and reduced EEG power across delta, theta, alpha, and beta frequency bands during the first 30 minutes, with recovery within 15 minutes. In the caudate nucleus, dopamine levels fell while dopamine turnover increased; serotonin levels rose in the frontal cortex. These physiological changes likely stem from ibogaine's interactions with multiple neurotransmitter systems.